Infinity Pharmaceuticals Company Insiders

INFIQ Stock   0.0001  0.00  0.00%   
Infinity Pharmaceuticals employs about 30 people. The company is managed by 2 executives with a total tenure of roughly 70 years, averaging almost 35.0 years of service per executive, having 15.0 employees per reported executive. Discussion of Infinity Pharmaceuticals' management performance can provide insight into the enterprise performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infinity Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Infinity Stock, please use our How to Invest in Infinity Pharmaceuticals guide.

Infinity Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.607) % which means that it has lost $0.607 on every $100 spent on assets. This is way below average. Infinity Pharmaceuticals' management efficiency ratios could be used to measure how well Infinity Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/30/2024, Return On Equity is likely to grow to 2.20, while Return On Tangible Assets are likely to drop (0.99). As of 11/30/2024, Liabilities And Stockholders Equity is likely to grow to about 59.2 M, while Total Current Liabilities is likely to drop slightly above 13.1 M.
As of 11/30/2024, Common Stock Shares Outstanding is likely to drop to about 80.2 M. In addition to that, Net Loss is likely to drop to about (54.7 M)

Infinity Pharmaceuticals Workforce Comparison

Infinity Pharmaceuticals is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 16,325. Infinity Pharmaceuticals adds roughly 30.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Infinity Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Infinity Pharmaceuticals Price Series Summation is a cross summation of Infinity Pharmaceuticals price series and its benchmark/peer.

Infinity Pharmaceuticals Notable Stakeholders

An Infinity Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Infinity Pharmaceuticals often face trade-offs trying to please all of them. Infinity Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Infinity Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Seth JDSenior CEOProfile
MD JDTreasurerProfile

About Infinity Pharmaceuticals Management Performance

The success or failure of an entity such as Infinity Pharmaceuticals often depends on how effective the management is. Infinity Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Infinity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Infinity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.95)(0.99)
Return On Capital Employed(1.81)(1.90)
Return On Assets(0.95)(0.99)
Return On Equity 2.10  2.20 

Infinity Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Infinity Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Infinity Pharmaceuticals within its industry.

Infinity Pharmaceuticals Manpower Efficiency

Return on Infinity Pharmaceuticals Manpower

Revenue Per Employee86.4K
Revenue Per Executive1.3M
Net Loss Per Employee1.5M
Net Loss Per Executive22.2M
Working Capital Per Employee889.1K
Working Capital Per Executive13.3M

Additional Tools for Infinity Stock Analysis

When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.